These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 20673370)
1. Development of the ATAQ-IPF: a tool to assess quality of life in IPF. Swigris JJ; Wilson SR; Green KE; Sprunger DB; Brown KK; Wamboldt FS Health Qual Life Outcomes; 2010 Jul; 8():77. PubMed ID: 20673370 [TBL] [Abstract][Full Text] [Related]
2. Cross-Atlantic modification and validation of the A Tool to Assess Quality of Life in Idiopathic Pulmonary Fibrosis (ATAQ-IPF-cA). Yorke J; Spencer LG; Duck A; Ratcliffe S; Kwong GN; Longshaw MS; Belkin A; Swigris JJ BMJ Open Respir Res; 2014; 1(1):e000024. PubMed ID: 25478176 [TBL] [Abstract][Full Text] [Related]
3. Development of ATAQ-LAM: a tool to assess quality of life in Lymphangioleiomyomatosis. Walker TD; Desserich J; Albright K; Wamboldt FS; Belkin A; Fier K; Swigris JJ Health Qual Life Outcomes; 2015 Jul; 13():112. PubMed ID: 26220448 [TBL] [Abstract][Full Text] [Related]
4. Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire. Swigris JJ; Andrae DA; Churney T; Johnson N; Scholand MB; White ES; Matsui A; Raimundo K; Evans CJ Am J Respir Crit Care Med; 2020 Dec; 202(12):1689-1697. PubMed ID: 32634038 [No Abstract] [Full Text] [Related]
5. Validation of a derived version of the IPF-specific Saint George's Respiratory Questionnaire. Prior TS; Hoyer N; Shaker SB; Davidsen JR; Hilberg O; Patel H; Bendstrup E Respir Res; 2021 Oct; 22(1):259. PubMed ID: 34610840 [TBL] [Abstract][Full Text] [Related]
6. Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis. Yount SE; Beaumont JL; Chen SY; Kaiser K; Wortman K; Van Brunt DL; Swigris J; Cella D Lung; 2016 Apr; 194(2):227-34. PubMed ID: 26861885 [TBL] [Abstract][Full Text] [Related]
7. Reliability and validity of Chinese version of a tool to assess the quality of life in idiopathic pulmonary fibrosis in patients with interstitial lung disease. Pan RL; Swigris JJ; Zhao YW; Guo AM; Wu Q; Li SJ Int J Nurs Sci; 2019 Jan; 6(1):38-42. PubMed ID: 31406867 [TBL] [Abstract][Full Text] [Related]
8. Development and validity testing of an IPF-specific version of the St George's Respiratory Questionnaire. Yorke J; Jones PW; Swigris JJ Thorax; 2010 Oct; 65(10):921-6. PubMed ID: 20861296 [TBL] [Abstract][Full Text] [Related]
10. Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Swigris JJ; Stewart AL; Gould MK; Wilson SR Health Qual Life Outcomes; 2005 Oct; 3():61. PubMed ID: 16212668 [TBL] [Abstract][Full Text] [Related]
11. Validation of the IPF-specific version of St. George's Respiratory Questionnaire. Prior TS; Hoyer N; Shaker SB; Davidsen JR; Yorke J; Hilberg O; Bendstrup E Respir Res; 2019 Aug; 20(1):199. PubMed ID: 31462235 [TBL] [Abstract][Full Text] [Related]
12. Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis. Witt S; Krauss E; Barbero MAN; Müller V; Bonniaud P; Vancheri C; Wells AU; Vasakova M; Pesci A; Klepetko W; Seeger W; Crestani B; Leidl R; Holle R; Schwarzkopf L; Guenther A Respir Res; 2019 Mar; 20(1):47. PubMed ID: 30823880 [TBL] [Abstract][Full Text] [Related]
13. The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review. Swigris JJ; Esser D; Conoscenti CS; Brown KK Health Qual Life Outcomes; 2014 Aug; 12():124. PubMed ID: 25138056 [TBL] [Abstract][Full Text] [Related]
14. The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Swigris JJ; Brown KK; Behr J; du Bois RM; King TE; Raghu G; Wamboldt FS Respir Med; 2010 Feb; 104(2):296-304. PubMed ID: 19815403 [TBL] [Abstract][Full Text] [Related]
15. Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease. Natalini JG; Swigris JJ; Morisset J; Elicker BM; Jones KD; Fischer A; Collard HR; Lee JS Respir Med; 2017 Jun; 127():1-6. PubMed ID: 28502413 [TBL] [Abstract][Full Text] [Related]
16. Content validity of CASA-Q cough domains and UCSD-SOBQ for use in patients with Idiopathic Pulmonary Fibrosis. Gries KS; Esser D; Wiklund I Glob J Health Sci; 2013 Sep; 5(6):131-41. PubMed ID: 24171881 [TBL] [Abstract][Full Text] [Related]
17. Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis. Swigris JJ; Streiner DL; Brown KK; Belkin A; Green KE; Wamboldt FS; Respir Med; 2014 Jan; 108(1):181-8. PubMed ID: 24388667 [TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life in idiopathic pulmonary fibrosis: where are we now? Belkin A; Swigris JJ Curr Opin Pulm Med; 2013 Sep; 19(5):474-9. PubMed ID: 23851327 [TBL] [Abstract][Full Text] [Related]
19. Translation to Spanish and Validation of the Specific Saint George's Questionnaire for Idiopathic Pulmonary Fibrosis. Capparelli I; Fernandez M; Saadia Otero M; Steimberg J; Brassesco M; Campobasso A; Palacios S; Caro F; Alberti ML; Rabinovich RA; Paulin F Arch Bronconeumol (Engl Ed); 2018 Feb; 54(2):68-73. PubMed ID: 29102341 [TBL] [Abstract][Full Text] [Related]
20. Development and Pretesting of a Questionnaire to Assess Patient Experiences and Satisfaction with Medications (PESaM Questionnaire). Kimman ML; Rotteveel AH; Wijsenbeek M; Mostard R; Tak NC; van Jaarsveld X; Storm M; Wijnsma KL; Gelens M; van de Kar NCAJ; Wetzels J; Dirksen CD Patient; 2017 Oct; 10(5):629-642. PubMed ID: 28357591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]